In a study of lung cancer cell lines using quantitative phosphoproteomics, approximately 40 different kinases were identified as dasatinib targets, including the SFKs LYN, SRC, YES, FYN, and LCK [21]. The gene discussed is YES1; the disease is lung cancer.